Answers are grounded in this paper and cite their sources.
Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide owing to delayed diagnosis and limited therapeutic options. Although neddylation has been implicated in tumor progression, its role in shaping the GC tumor microenvironment (TME) remains poorly understood. This study aimed to investigate the prognostic significance of neddylation-related genes (NRGs) and their association with the TME in GC. The TCGA-STAD cohort was used for prognostic model development, and the GSE62254 cohort was used for external validation. In addition, all available patient-matched GC and adjacent normal tissue pairs from 20 GEO datasets and TCGA-STAD were analyzed to evaluate the expression patterns of the six model genes. A prognostic Neddylation-Score was established using least absolute shrinkage and selection operator (LASSO) and Cox regression analyses. An immune-cell-derived TME-Score was constructed based on prognostically relevant immune-cell fractions estimated by CIBERSORT. OLFML2B protein expression was validated by Western blotting in six paired GC and adjacent normal tissues. The biological functions of OLFML2B were further evaluated through in vitro assays and a xenograft mouse model. Six prognostic NRGs were identified and incorporated into the Neddylation-Score, which effectively stratified patients according to overall survival. Integration of the Neddylation-Score and TME-Score further stratified patients into distinct prognostic groups, with patients exhibiting high Neddylation-Scores and low TME-Scores showing the poorest outcomes. Among the six genes, OLFML2B was significantly upregulated in GC tissues and associated with unfavorable prognosis. Silencing OLFML2B inhibited GC cell proliferation, migration, and invasion in vitro and suppressed tumor growth in vivo. Mechanistically, OLFML2B knockdown attenuated nuclear factor kappa B (NF-κB) signaling, as indicated by reduced phosphorylation of IKKβ and IκBα and decreased nuclear translocation of p65. NRG-based signatures were associated with prognosis and TME characteristics in GC. OLFML2B promoted GC progression through activation of the NF-κB pathway and may represent a candidate prognostic biomarker and potential therapeutic target. Further prospective and clinical validation is required to establish the clinical utility of these findings.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: